Seres Therapeutics Inc Sustainability Reports
Seres Therapeutics, Inc. is a commercial-stage biotechnology company that develops microbiome therapeutics platform and novel classes of biological drugs. The company targets the underlying biology of the human microbiome to treat various serious diseases and repair microbiome function.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300GMXBE5NUWISF13
FIGI: BBG0099X6868
4 reports from 2017 to 2024